Cartography.bio is a pioneering startup operating in the field of cancer therapeutics. The company's primary focus is on developing cancer immunotherapies that are as precise as their targets. They aim to design treatments that are not only safe but also highly effective. The company serves a broad range of clients, including healthcare providers and patients, particularly those suffering from various types of cancer.

The company operates in the healthcare market, specifically in the cancer therapeutics sector. It uses a unique approach to target identification, analyzing cancers through the lens of antigen expression rather than histology or genetic mutations. This innovative method allows the company to identify potential targets for cancer treatment that were previously overlooked.

Cartography.bio's business model revolves around the development and commercialization of precision cancer therapeutics. The company generates revenue by creating and selling these innovative therapies. They also aim to find druggable targets for cancers that are currently untreatable and create therapeutics that are specific enough to only engage tumor cells, broad enough to target every cell in a patient’s tumor, and safe enough to minimize toxic side effects.

In summary, Cartography.bio is a forward-thinking startup that is revolutionizing the field of cancer therapeutics by developing precise and effective immunotherapies. The company's unique approach to target identification and its commitment to creating safe and effective treatments make it a promising player in the healthcare market.

Keywords: Cancer Therapeutics, Immunotherapies, Precision Medicine, Target Identification, Antigen Expression, Healthcare Market, Drug Discovery, Tumor Cells, Toxic Side Effects, Revenue Generation.